91Â鶹ÌìÃÀÖ±²¥

Amit Maity
( out of 10 reviews )

Amit Maity, MD, PhD, FASTRO

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital South

Radiation Oncology
Salt Lake City

  • Amit Maity is Professor and Chair of the Department of Radiation Oncology at the University of Utah School of Medicine where he holds the Huntsman Cancer Institute Endowed Chair in Cancer Research. In this role, he leads the efforts of faculty and staff in the department located in the Huntsman Cancer Hospital to provide clinical care to patients requiring radiation treatment and also promotes the educational and research missions of the department. He received an MD at Boston University School of Medicine, then completed a residency in internal medicine at Mount Sinai Hospital in New York, a residency in radiation oncology at the Hospital of the University of Pennsylvania in Philadelphia, and a PhD in pathology at the University of Pennsylvania.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Radiology (Radiation Oncology)

    Patient Rating

    4.8 /5
    ( out of 10 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 29, 2024
    HUNTSMAN CANCER CENTER

    Dr. Maity was respectful, caring, and careful to explain medical options in layman's terms.

    June 29, 2024
    HUNTSMAN CANCER CENTER

    Dr. Maity is very kind and helpful. He fully explained each step of my treatment and follow-up and allowed me to ask questions and comment on each step of my medical journey.

    June 07, 2024
    HUNTSMAN CANCER CENTER

    Genuine concern for my recovery and continued health.

    March 15, 2024
    HUNTSMAN CANCER CENTER

    Straight forward, empathetic, knows his job, focused and wise. Confident in his abilities.

    March 02, 2024
    HUNTSMAN CANCER CENTER

    Amazing doctor

    November 30, 2023
    HUNTSMAN CANCER CENTER

    Hr was, very friendly and thorough explaining the radiation I was going to receive and how it was going to be delivered showing me the treatment plan work up and yhe palate itself, which I found fascinating.. He also tested my pperiphal vision on both sides. As well as my skkellital muscular strength by having me push back against resistance from himself. He went over my medical history and answered all of my questions. After administering the consent form for the radiation, he introduced Mr to a pyhsist whom I think was named Marley who was from Boise. He went into more detail about the palate to be inserted and several pages of photos of my eye and the 28 seeds of radiation that were going to used. He was also very friendly. I saw him again as I was going into surgery. My whole experience Could not have been better. Please excuse my typing I have use of only one eye and it is the weaker of the two.

    November 03, 2023
    HUNTSMAN CANCER CENTER

    Excelente doctor y muy amable

    August 05, 2023
    HUNTSMAN CANCER CENTER

    Dr Maity explained the goals of my treatment plan, several different options to reach that goal, and then he let me choose the option that made sense to me.

    July 11, 2023
    HUNTSMAN CANCER CENTER

    It was a great experience meeting with Doctor Maity. He is so knowledgeable and personable and relates so well with his patients. He honors my decisions, due to my age, going forward with any treatments that I don't feel like I want to pursue. Although he said he is easy to contact and there if ever I need further advice.

    See More Patient Comments

  • Amit Maity is Professor and Chair of the Department of Radiation Oncology at the University of Utah School of Medicine where he holds the Huntsman Cancer Institute Endowed Chair in Cancer Research. In this role, he leads the efforts of faculty and staff in the department located in the Huntsman Cancer Hospital to provide clinical care to patients requiring radiation treatment and also promotes the educational and research missions of the department. He received an MD at Boston University School of Medicine, then completed a residency in internal medicine at Mount Sinai Hospital in New York, a residency in radiation oncology at the Hospital of the University of Pennsylvania in Philadelphia, and a PhD in pathology at the University of Pennsylvania.

    Board Certification and Academic Information

    Academic Departments Radiation Oncology -Primary
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Radiology (Radiation Oncology)

    Education history

    Other Training Leadership Development Program - Harvard School of Public Health
    Postdoctoral Training Johns Hopkins University School of Medicine Postdoctoral Researcher
    Doctoral Training Pathology - University of Pennsylvania Ph.D.
    Postdoctoral Training University of Pennsylvania School of Medicine Postdoctoral Training
    Fellowship Radiation Oncology - Hospital of the University of Pennsylvania Fellow
    Residency Radiation Oncology - Hospital of the University of Pennsylvania Resident
    Residency Internal Medicine - Mount Sinai Hospital Resident
    Internship Internal Medicine - Mount Sinai Hospital Intern
    Professional Medical Medicine - Boston University School of Medicine M.D.
    Undergraduate Mathematics - Boston University B.A.

    Selected Publications

    Journal Article

    1. Baron JA, Wright CM, Dreyfuss AD, Chong EA, Svoboda J, LaRiviere MJ, Jones JA, Maity A, Plastaras JP, Paydar I, Maxwell R (2024). Radiotherapy dose response in bulky relapsed/refractory large B-cell lymphoma. Pract Radiat Oncol. ()
    2. Perales-Linares R, Leli NM, Mohei H, Beghi S, Rivera OD, Kostopoulos N, Giglio A, George SS, Uribe-Herranz M, Costabile F, Pierini S, Pustylnikov S, Skoufos G, Barash Y, Hatzigeorgiou AG, Koumenis C, Maity A, Lotze MT, Facciabene A (2023). Parkin deficiency suppresses antigen presentation to promote tumor immune evasion and immunotherapy resistance. Cancer Res. ()
    3. Fenlon JB, Hutten RJ, Johnson SB, Hu B, Shah H, Stephens DM, Maity A, Gaffney DK, Tao R (2022). Evaluating patterns of care for early-stage low-grade follicular lymphoma in the rituximab era. Leuk Lymphoma, 64(2), 356-363. ()
    4. Yegya-Raman N, Wright CM, LaRiviere MJ, Baron JA, Lee DY, Landsburg DJ, Svoboda J, Nasta SD, Gerson JN, Barta SK, Chong EA, Schuster SJ, Maity A, Facciabene A, Paydar I, Plastaras JP (2023). Salvage radiotherapy for relapsed/refractory non-Hodgkin lymphoma following CD19 chimeric antigen receptor T-cell (CART) therapy. Clin Transl Radiat Oncol, 39, 100587. ()
    5. Zou W, Kim H, Diffenderfer ES, Carlson DJ, Koch CJ, Xiao Y, Teo BK, Kim MM, Metz JM, Fan Y, Maity A, Koumenis C, Busch TM, Wiersma R, Cengel KA, Dong L (2022). A phenomenological model of proton FLASH oxygen depletion effects depending on tissue vasculature and oxygen supply. Front Oncol, 12, 1004121. ()
    6. Baron JA, Wright CM, Maxwell R, Kim MM, Giap F, Vega RBM, Hoppe BS, LaRiviere MJ, Maity A, Plastaras JP, Paydar I (2022). Proton Radiation Therapy After Chemotherapy in the Management of Aggressive Mediastinal Non-Hodgkin Lymphomas: A Particle Therapy Cooperative Group Lymphoma Subcommittee Collaboration. Adv Radiat Oncol, 8(1), 101090. ()
    7. Anstadt EJ, Chu B, Yegya-Raman N, Han X, Doucette A, Poirier K, Mohiuddin JJ, Maity A, Facciabene A, Amaravadi RK, Karakousis GC, Cohen JV, Mitchell TC, Schuchter LM, Lukens JN (2021). Moderate Colitis Not Requiring Intravenous Steroids Is Associated with Improved Survival in Stage IV Melanoma after Anti-CTLA4 Monotherapy, But Not Combination Therapy. Oncologist, 27(9), 799-808. ()
    8. Freyer CW, Babushok DV, Frey NV, Gill SI, Loren AW, Luger SM, Maity A, Martin ME, Plastaras JP, Porter DL, Hexner EO (2022). Low-Dose Total Body Irradiation Added to Fludarabine and Busulfan Reduced-Intensity Conditioning Reduces Graft Failure in Patients with Myelofibrosis. Transplant Cell Ther, 28(9), 590-596. ()
    9. Wright CM, Dreyfuss AD, Baron JA, Maxwell R, Mendes A, Barsky AR, Doucette A, Svoboda J, Chong EA, Jones JA, Maity A, Plastaras JP, Paydar I (2022). Radiation Therapy for Relapsed or Refractory Diffuse Large B-Cell Lymphoma: What Is the Right Regimen for Palliation? Adv Radiat Oncol, 7(6), 101016. ()
    10. Zhong L, Yao L, Holdreith N, Yu W, Gui T, Miao Z, Elkaim Y, Li M, Gong Y, Pacifici M, Maity A, Busch TM, Joeng KS, Cengel K, Seale P, Tong W, Qin L (2022). Transient expansion and myofibroblast conversion of adipogenic lineage precursors mediate bone marrow repair after radiation. JCI Insight, 7(7). ()
    11. Demissei BG, Freedman G, Feigenberg SJ, Plastaras JP, Maity A, Smith AM, McDonald C, Sheline K, Simone CB 2nd, Lin LL, Carver JR, Liu P, Zhang L, Bekelman JE, Ky B (2018). Early Changes in Cardiovascular Biomarkers with Contemporary Thoracic Radiation Therapy for Breast Cancer, Lung Cancer, and Lymphoma. Int J Radiat Oncol Biol Phys, 103(4), 851-860. ()

    Review

    1. Zou W, Zhang R, Schler E, Taylor PA, Mascia AE, Diffenderfer ES, Zhao T, Ayan AS, Sharma M, Yu SJ, Lu W, Bosch WR, Tsien C, Surucu M, Pollard-Larkin JM, Schuemann J, Moros EG, Bazalova-Carter M, Gladstone DJ, Li H, Simone CB 2nd, Petersson K, Kry SF, Maity A, Loo BW Jr, Dong L, Maxim PG, Xiao Y, Buchsbaum JC (2023). Framework for Quality Assurance of Ultrahigh Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology Gaps. [Review]. Int J Radiat Oncol Biol Phys, 116(5), 1202-1217. ()
    2. Graves EE, Maity A, Le QT (2010). The tumor microenvironment in non-small-cell lung cancer. [Review]. Semin Radiat Oncol, 20(3), 156-63. ()

    Conference Proceedings

    1. Zhu Y, Alexander DA, Miao T, Maity A, Plastaras JP, Paydar I, LaRiviere M, Pogue BW, Zhu TC (2023). Evaluation of the cumulative Cherenkov converted dose on TSET patients with multiple Cherenkov cameras. Proc SPIE Int Soc Opt Eng, United States, 12359. ()